Showing results (11-20 of 76) with videos related to
Sort By:
Pageof 8
Journal of Geriatric Oncology|May 17, 2021
Treatment patterns in older patients with locally advanced head and neck squamous cell carcinoma: Results from an EORTC led surveySjoukje F Oosting, Isacco Desideri, Dominiek Staelens, et al.The Journal of Laryngology and Otology|January 18, 2024
Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal functionArman Nobacht, Tineke W H Meijer, Sjoukje F Oosting, et al.Nature Reviews. Clinical Oncology|November 28, 2018
Integrating molecular nuclear imaging in clinical research to improve anticancer therapyElisabeth G E de Vries, Laura Kist de Ruijter, Marjolijn N Lub-de Hooge, et al.Pathology Oncology Research : POR|September 4, 2019
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare CancersMarloes A M Peters, Coby Meijer, Rudolf S N Fehrmann, et al.Journal of Cancer Research and Clinical Oncology|January 29, 2024
Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic areaJort S van Velsen, Bert van der Vegt, Boudewijn E C Plaat, et al.Oral Oncology|July 27, 2019
The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-)radiationTian-Tian Zhai, Johannes A Langendijk, Lisanne V van Dijk, et al.Familial Cancer|November 17, 2011
Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillanceKarin Y van Spaendonck-Zwarts, Sadhanna Badeloe, Sjoukje F Oosting, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2022
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell CarcinomaMartin H Voss, Arun A Azad, Aaron R Hansen, et al.Oral Oncology|February 29, 2024
Identification of new head and neck squamous cell carcinoma molecular imaging targetsJeroen E van Schaik, Bert van der Vegt, Lorian Slagter-Menkema, et al.Journal for Immunotherapy of Cancer|August 3, 2022
Molecular imaging to support cancer immunotherapyPim P van de Donk, Sjoukje F Oosting, Daan G Knapen, et al.Pageof 8